Search for Clinical Trial Results
Adenoma - 646 Studies Found
Status | Study |
Active, not recruiting |
Study Name: The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study Condition: Familial Adenomatous Polyposis Date: 2012-10-31 Interventions: Drug: metformin Patients will be randomly assigned in a 2:2:1 ratio to receive metformin or identical-ap |
Active, not recruiting |
Study Name: Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Condition: FAP-Familial Adenomatous Polyposis Date: 2012-11-26 Interventions: Drug: Erythromycin Oral Treatment with Erythromycin 500mg, twice daily, for 12 weeks |
Not yet recruiting |
Study Name: Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version Condition: FAP-Familial Adenomatous Polyposis Date: 2015-01-21 Interventions: Drug: Erythromycin Oral Treatment with Erythromycin 250-500mg, twice daily, for 16 weeks.Exact dose is s |
Recruiting |
Study Name: Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program Condition:
|
Terminated |
Study Name: Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients Condition: Familial Adenomatous Polyposis (FAP) Date: 2005-09-07 Interventions:
|
Completed |
Study Name: Curcumin in Treating Patients With Familial Adenomatous Polyposis Condition: Familial Adenomatous Polyposis Date: 2008-03-17 Interventions:
|
Active, not recruiting |
Study Name: Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP) Condition: Familial Adenomatous Polyposis Date: 2009-06-24 Interventions:
|
Withdrawn |
Study Name: A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP) Condition: Familial Adenomatous Polyposis Date: 2010-11-19 Interventions:
|
Not yet recruiting |
Study Name: Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer Condition:
|
Terminated |
Study Name: Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis Condition:
Date: 2002-04-09 Interventions:
|